Company news

Recursion Pharmaceuticals, Inc. news in 2023

Recursion Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

December 19, 2023

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

November 8, 2023

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

November 8, 2023

Bayer and Recursion Focus Research Collaboration on Oncology

November 8, 2023

Bayer and Recursion focus research collaboration on Oncology

November 8, 2023

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

September 4, 2023

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

August 7, 2023

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

August 7, 2023

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

July 25, 2023

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

July 11, 2023

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

June 25, 2023

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

June 12, 2023

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

May 15, 2023

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

May 7, 2023

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

May 7, 2023

Recursion Publishes Second Annual Environmental, Social and Governance Report

March 27, 2023

Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day

January 25, 2023

Decks in 2023